Market Overview:
The global mirtazapine drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of depression and anxiety disorders, rising geriatric population, and growing demand for novel antidepressants. Based on type, the global mirtazapine drug market is segmented into 15mg tablet, 30mg tablet, and 45mg tablet segments. The 30mg tablet segment is expected to account for the largest share of the global mirtazapine drug market in 2018. This segment is also projected to grow at a CAGR of 5.7% during the forecast period from 2018 to 2030. Based on application, the global mirtazapine drug market is divided into hospital and drug store segments. The hospital segment accounted for majority share of revenue generated by this market in 2017 and it is anticipated that this trend will continue over next few years as well owing high adoption rate among hospitals across different regions globally coupled with rising number of patients suffering from mental health disorders such as depression & anxiety disorder which requires immediate medical attention & treatment . However ,the Drug Store Segment Is Expected To Grow At A Higher Rate Than Hospital Segment During Forecast Period Due To Rising Prevalence Of Mental Health Disorders Such As Depression And Anxiety Disorder In Developing Countries .
Product Definition:
Mirtazapine is a drug used to treat depression. It is in a class of drugs called tetracyclic antidepressants (TCAs). Mirtazapine works by increasing the activity of serotonin and norepinephrine in the brain.
15mg Tablet:
15mg tablet is a form of the drug Mirtazapine used for the treatment of depression and anxiety. It’s an anti-depressant drug which works by increasing serotonin levels in the brain, therefore making a person feel better. The medicine was first developed in Spain and later approved by the U.
30mg Tablet:
Mirtazapine is an anti-epileptic drug developed by the pharmaceutical company GlaxoSmithKline. It was first approved in 1999 in the U.S and 2000 in Europe for the treatment of seizures associated with epilepsy, which are also known as epileptic seizures or convulsions.
Application Insights:
The drug is used for the treatment of depression, anxiety disorders and sleep disorder. Major depressive disorder accounted for the largest share in 2017 owing to increasing prevalence of mental illness coupled with rising awareness among individuals suffering from depression regarding proper treatment. Mirtazapine tablets are also used off label to treat social anxiety disorder, post-traumatic stress disorder (PTSD), panic disorders and other phobias. However, there are no adequate clinical trials supporting its use for these purposes which restricts its scope as a medication.
Mirtazapine is an effective anxiolytic agent with low abuse potential and has high preference as an anti-depressant due to its non-stimulant properties compared to other antidepressants such as SSRIs & SNRIs. It has been approved by FDA under federal law under 21 CFR part 1450 regulations for marketing only within the U.S.
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand and availability of a well-established healthcare infrastructure. Moreover, increasing prevalence of anxiety disorders is expected to drive the region’s growth over the forecast period. Asia Pacific is estimated to be the fastest-growing region during the forecast years due to rising geriatric population, improving economic conditions, and growing awareness about mental health among people. Furthermore, expansion of retail pharmacies in countries such as India and China will boost mirtazapine drug sales over this period.
Moreover, factors such as favorable government initiatives for early diagnosis & management coupled with increased spending on healthcare are expected to drive industry growth across Latin America during 2018 - 2030 time frame.
Growth Factors:
- Increasing prevalence of depression and anxiety disorders
- Rising awareness about the benefits of Mirtazapine drug therapy
- Growing demand for better-tolerated antidepressants with fewer side effects
- Availability of generic versions of Mirtazapine drug
- Expanding research on new indications for Mirtazapine
Scope Of The Report
Report Attributes
Report Details
Report Title
Mirtazapine Drug Market Research Report
By Type
15mg Tablet, 30mg Tablet, 45mg Tablet
By Application
Hospital, Drug Store
By Companies
Merck & Co, Sandoz, Teva, Mylan, Sun Pharmaceutical, IMPAX, Aurobindo Pharma, Zydus Pharmaceuticals, APOTEX
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
191
Number of Tables & Figures
134
Customization Available
Yes, the report can be customized as per your need.
Global Mirtazapine Drug Market Report Segments:
The global Mirtazapine Drug market is segmented on the basis of:
Types
15mg Tablet, 30mg Tablet, 45mg Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck & Co
- Sandoz
- Teva
- Mylan
- Sun Pharmaceutical
- IMPAX
- Aurobindo Pharma
- Zydus Pharmaceuticals
- APOTEX
Highlights of The Mirtazapine Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 15mg Tablet
- 30mg Tablet
- 45mg Tablet
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mirtazapine Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mirtazapine is a drug that is used to treat depression. It works by affecting the chemicals in the brain that may be responsible for causing depression.
Some of the key players operating in the mirtazapine drug market are Merck & Co, Sandoz, Teva, Mylan, Sun Pharmaceutical, IMPAX, Aurobindo Pharma, Zydus Pharmaceuticals, APOTEX.
The mirtazapine drug market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mirtazapine Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mirtazapine Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mirtazapine Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mirtazapine Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mirtazapine Drug Market Size & Forecast, 2018-2028
4.5.1 Mirtazapine Drug Market Size and Y-o-Y Growth
4.5.2 Mirtazapine Drug Market Absolute $ Opportunity
Chapter 5 Global Mirtazapine Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mirtazapine Drug Market Size Forecast by Type
5.2.1 15mg Tablet
5.2.2 30mg Tablet
5.2.3 45mg Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mirtazapine Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mirtazapine Drug Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mirtazapine Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mirtazapine Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mirtazapine Drug Analysis and Forecast
9.1 Introduction
9.2 North America Mirtazapine Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mirtazapine Drug Market Size Forecast by Type
9.6.1 15mg Tablet
9.6.2 30mg Tablet
9.6.3 45mg Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mirtazapine Drug Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mirtazapine Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Mirtazapine Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mirtazapine Drug Market Size Forecast by Type
10.6.1 15mg Tablet
10.6.2 30mg Tablet
10.6.3 45mg Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mirtazapine Drug Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mirtazapine Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mirtazapine Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mirtazapine Drug Market Size Forecast by Type
11.6.1 15mg Tablet
11.6.2 30mg Tablet
11.6.3 45mg Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mirtazapine Drug Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mirtazapine Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Mirtazapine Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mirtazapine Drug Market Size Forecast by Type
12.6.1 15mg Tablet
12.6.2 30mg Tablet
12.6.3 45mg Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mirtazapine Drug Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mirtazapine Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mirtazapine Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mirtazapine Drug Market Size Forecast by Type
13.6.1 15mg Tablet
13.6.2 30mg Tablet
13.6.3 45mg Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mirtazapine Drug Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mirtazapine Drug Market: Competitive Dashboard
14.2 Global Mirtazapine Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck & Co
14.3.2 Sandoz
14.3.3 Teva
14.3.4 Mylan
14.3.5 Sun Pharmaceutical
14.3.6 IMPAX
14.3.7 Aurobindo Pharma
14.3.8 Zydus Pharmaceuticals
14.3.9 APOTEX
